 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News Europe Approves New Formulation of Abbott HIV DrugJuly 5, 2006 On Monday, Abbott Laboratories announced the European Commission has granted approval to a new formulation of its HIV drug Kaletra requiring fewer doses and no refrigeration. U.S. regulators approved the innovation in October; the EC's approval was expected, given a positive evaluation by a panel of European Union experts in April. Adults on the new formulation will need to take four pills daily, with or without food, instead of the current six. In addition, Abbott said the EC's decision will help it seek approval in developing nations where refrigeration is scarce. Reuters 07.03.06  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
